THE HBF PILL Trademark

Trademark Overview

On Friday, February 11, 2022, a trademark application was filed for THE HBF PILL with the United States Patent and Trademark Office. The USPTO has given the THE HBF PILL trademark a serial number of 97264241. The federal status of this trademark filing is REGISTERED as of Tuesday, May 9, 2023. This trademark is owned by Fulcrum Therapeutics, Inc.. The THE HBF PILL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of hematological rare and genetically defined diseases and disorders
the hbf pill

General Information

Serial Number97264241
Word MarkTHE HBF PILL
Filing DateFriday, February 11, 2022
Status700 - REGISTERED
Status DateTuesday, May 9, 2023
Registration Number7050850
Registration DateTuesday, May 9, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of hematological rare and genetically defined diseases and disorders
NOT AVAILABLE"PILL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 16, 2022
Primary Code005
First Use Anywhere DateWednesday, February 15, 2023
First Use In Commerce DateWednesday, February 15, 2023

Trademark Owner History

Party NameFulcrum Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameFulcrum Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Wednesday, February 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 15, 2022NEW APPLICATION ENTERED
Sunday, November 27, 2022ASSIGNED TO EXAMINER
Tuesday, December 13, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 13, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 13, 2023TEAS AMENDMENT OF USE RECEIVED
Monday, March 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 14, 2023USE AMENDMENT FILED
Tuesday, March 14, 2023AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, March 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 16, 2023USE AMENDMENT ACCEPTED
Thursday, March 16, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, March 17, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, March 30, 2023ASSIGNED TO LIE
Tuesday, April 4, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 9, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 9, 2023REGISTERED-SUPPLEMENTAL REGISTER
Friday, February 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 5, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 5, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

pill defined diseases disorders genetically rare treatment hematological pharmaceuticals